by Jon C. Ogg
ACA started as Outperform at Credit Suisse; started as Overweight at JPMorgan.
ALAB started as Overweight at JPMorgan.
ALY started as Buy at AGEdwards.
ASML started as Overweight at Thomas Weisel.
BCE raised to Buy at Merrill Lynch.
BKUNA started as Overweight at JPMorgan.
COH started as Buy at Citigroup.
CMX cut to Equal Weight at Morgan Stanley.
CPLA started as Buy at B of A.
DNA removed from Conviction Buy List (Americas) at Goldman Sachs.
ERJ cut to Underperform at Bear Stearns.
F raised to Hold at KeyBanc/McDonald.
FACE started as Outperform at Piper Jaffray (yesterday).
FTWR started as Buy at Jefferies.
GE added to Recommend List at Prudential.
GFIG started as Buy at Deutsche Bank.
GILD started as Buy/$78 target at Goldman Sachs.
HANS started as Buy at Stifel Nicolaus.
ITG started as Buy at Deutsche Bank.
KSS cut to Neutral at RWBaird.
JNPR cut to Sector PErform at CIBC (based on RBAK buyout).
LAUR started as Hold at Citigroup.
MBLX started as Buy at Jefferies.
MDR started as Outperform at Wachovia.
MEDI added to Conviction Buy List (Americas) at Goldman Sachs.
NHWK raised to Overweight at Morgan Stanley.
NITE started as Buy at Deutsche Bank.
PAA cut to Hold at Deutsche Bank.
PANC cut to Peer Perform at Bear Stearns.
PLMD started as Buy at BB&T.
SBH cut to Underweight at Prudential.
STO cut to Hold at Citigroup.
SYMC added to Conviction Buy List (Americas) at Goldman Sachs.
TU raised to Buy at Merrill Lynch.
VCI cut to Neutral at RWBaird.